Literature DB >> 16314696

Magnetic resonance angiography of abdominal and lower extremity vasculature.

Tim Leiner1.   

Abstract

Magnetic resonance angiography (MRA) has evolved over the past years from an experimental imaging modality to a technique that is now widely applied in clinical practice. This article reviews the fundamentals of the different magnetic resonance angiographic techniques and how they can be applied for abdominal and peripheral arterial imaging. Currently, contrast-enhanced magnetic resonance angiography (CE-MRA), whereby a luminogram is obtained during initial arterial passage of contrast material, is the most widely used technique. With current hardware and software, high-spatial resolution images of the abdominal aorta and proximal visceral branches can be obtained that are equivalent to intra-arterial digital subtraction angiography (IA-DSA). High-quality imaging of the renal arteries demands isotropic voxels and reformations orthogonal to the vessel axis for evaluation. Contrast-enhanced magnetic resonance angiography of the peripheral vascular tree is now a highly accurate technique and has replaced diagnostic intra-arterial digital subtraction angiography and duplex ultrasonography in many hospitals.

Mesh:

Substances:

Year:  2005        PMID: 16314696     DOI: 10.1097/01.rmr.0000185431.50535.d7

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  8 in total

Review 1.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

2.  Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression.

Authors:  Tim Leiner; Jesse Habets; Bastiaan Versluis; Liesbeth Geerts; Eveline Alberts; Niels Blanken; Jeroen Hendrikse; Evert-Jan Vonken; Holger Eggers
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

3.  Steady-state equilibrium phase inversion recovery ON-resonant water suppression (IRON) MR angiography in conjunction with superparamagnetic nanoparticles. A robust technique for imaging within a wide range of contrast agent dosages.

Authors:  Gitsios Gitsioudis; Matthias Stuber; Ingolf Arend; Moritz Thomas; Jing Yu; Thomas Hilbel; Evangelos Giannitsis; Hugo A Katus; Grigorios Korosoglou
Journal:  J Magn Reson Imaging       Date:  2013-02-15       Impact factor: 4.813

4.  Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.

Authors:  M Voth; Henrik J Michaely; C Schwenke; B Vos; H Pietsch
Journal:  Eur Radiol       Date:  2010-09-01       Impact factor: 5.315

5.  Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging.

Authors:  Suzanne C Gerretsen; M Eline Kooi; Alfons G Kessels; Simon Schalla; Marcus Katoh; Rob J van der Geest; Warren J Manning; Johannes Waltenberger; Jos M A van Engelshoven; Rene M Botnar; Tim Leiner
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

Review 6.  Recent advances in magnetic resonance imaging for peripheral artery disease.

Authors:  Roshin C Mathew; Christopher M Kramer
Journal:  Vasc Med       Date:  2018-04       Impact factor: 3.239

Review 7.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

Authors:  Tim Leiner; Jan Bogaert; Matthias G Friedrich; Raad Mohiaddin; Vivek Muthurangu; Saul Myerson; Andrew J Powell; Subha V Raman; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-09       Impact factor: 5.364

Review 8.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Authors:  Jessica Lohrke; Thomas Frenzel; Jan Endrikat; Filipe Caseiro Alves; Thomas M Grist; Meng Law; Jeong Min Lee; Tim Leiner; Kun-Cheng Li; Konstantin Nikolaou; Martin R Prince; Hans H Schild; Jeffrey C Weinreb; Kohki Yoshikawa; Hubertus Pietsch
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.